Mannitol 20%

Welcome to Dwaey, specifically on Mannitol 20% page.
This medicine contains important and useful components, as it consists of
Mannitol 20% is available in the market in concentration.

Generic Name of Mannitol 20% - Learn More

Mannitol 20%

Mannitol 20% Precaution - What You Need to Know

Before initiating Mannitol 20%, it is essential for patients to consult their healthcare provider to assess the safety of this drug in their specific case. Several precautions must be considered:

- Renal Impairment: Mannitol is contraindicated in patients with severe renal impairment (e.g., anuria or acute kidney failure), as it can worsen renal function due to renal filtration issues. In patients with pre-existing kidney disease, close monitoring of renal function is essential.
- Dehydration and Electrolyte Imbalance: Mannitol can cause fluid shifts and electrolyte imbalances, particularly hypernatremia and dehydration. Careful monitoring of serum electrolytes, especially sodium and potassium, is necessary during infusion.
- Pulmonary Edema: Caution should be taken when administering Mannitol 20% to patients with pulmonary edema or heart failure, as it can exacerbate fluid overload and cause cardiac complications.
- Intracranial Hemorrhage: While Mannitol is often used for reducing intracranial pressure, it must be used with caution in patients with active bleeding, as it can expand the blood volume and increase bleeding.
- Use in Pregnancy: Mannitol 20% should be used in pregnant women only if the potential benefit justifies the risk to the fetus. It falls under category C, meaning its safety during pregnancy has not been well established.
- Liver Dysfunction: Caution should be exercised when administering Mannitol 20% to patients with liver dysfunction since their ability to handle fluids and electrolytes may be impaired.
- Infusion Rate: Mannitol should be infused at the recommended rate to avoid rapid changes in fluid balance, which can lead to severe adverse effects, including hypotension and hyperkalemia.

Mannitol 20% Indication - Uses and Benefits

Mannitol 20% infusion is primarily used in the following medical conditions:

- Intracranial Hypertension: Mannitol 20% is commonly used to reduce intracranial pressure (ICP) in conditions such as traumatic brain injury, brain tumors, cerebral edema, and intracranial hemorrhage. It works by drawing fluid out of the brain tissue into the bloodstream, thereby reducing swelling and pressure.
- Acute Glaucoma: It is used to lower intraocular pressure (IOP) in cases of acute angle-closure glaucoma. Mannitol 20% reduces the pressure in the eyes by drawing fluid from the eye into the bloodstream.
- Renal Protection: It can be used as an adjunct to prevent renal failure in conditions where renal perfusion may be compromised, such as in patients undergoing cardiac surgery or trauma.
- Promoting Diuresis: Mannitol can help promote urine formation in acute kidney injury (AKI) and oliguric conditions where the kidneys are not producing sufficient urine.
- Drug Overdose: Mannitol 20% is sometimes used to enhance the elimination of certain toxins or poisons by osmotic diuresis.

Mannitol 20% Contraindications - Important Warnings

Mannitol 20% should not be administered in the following conditions:

- Anuria: Mannitol is contraindicated in patients with anuria (lack of urine production), as its diuretic effect requires functioning kidneys to filter and excrete fluids.
- Severe Renal Failure: Patients with severe renal impairment, particularly those with acute renal failure or chronic kidney disease, should not receive Mannitol 20%, as it could worsen renal function.
- Active Cerebral Hemorrhage: In patients with active intracranial hemorrhage, the use of Mannitol may worsen bleeding or lead to worsened intracranial pressure.
- Severe Pulmonary Edema: It should be avoided in patients with severe pulmonary edema, as it can exacerbate fluid overload and respiratory distress.
- Severe Dehydration: In cases of severe dehydration, Mannitol 20% should not be used due to its diuretic effects, which can further deplete the body of water and electrolytes.

Mannitol 20% Side Effects - What to Expect

Common and serious side effects associated with Mannitol 20% include:

- Electrolyte Imbalances: Patients may experience hyponatremia (low sodium) or hypernatremia (high sodium) due to the diuretic effect of Mannitol. Hypokalemia (low potassium) may also occur, leading to muscle weakness and arrhythmias.
- Dehydration: The osmotic diuretic action of Mannitol can lead to dehydration, causing symptoms such as thirst, dry mouth, and decreased urine output. This can be especially dangerous in patients who are already dehydrated.
- Hypotension: Mannitol can cause low blood pressure (hypotension), particularly when administered rapidly or in high doses. This can lead to dizziness, lightheadedness, and fainting.
- Headache: Mannitol infusion may lead to headache due to changes in fluid balance and intracranial pressure.
- Nausea and Vomiting: Patients receiving Mannitol 20% may experience nausea and vomiting, particularly when the infusion is given too rapidly.
- Pulmonary Edema: In rare cases, Mannitol can exacerbate pulmonary edema, especially in patients with underlying cardiac or lung conditions, leading to shortness of breath, coughing, and fluid retention in the lungs.
- Renal Failure: Overuse or improper dosing of Mannitol 20% can lead to acute renal failure, especially in patients with pre-existing kidney conditions.
- Extravasation: If Mannitol 20% is inadvertently infused outside the vein, it can cause significant tissue damage or extravasation injury.

Serious side effects such as respiratory failure, severe dehydration, and cardiac arrhythmias require immediate medical attention.

Mannitol 20% Pregnancy Category ID - Safety Information

3

Mannitol 20% Mode of Action - How It Works

Mannitol 20% acts primarily as an osmotic diuretic, exerting its effects by creating an osmotic gradient that draws water from tissues into the bloodstream, increasing urine production. Here's how it works:

- Increased Plasma Volume: Mannitol increases the plasma volume, which can help reduce intracranial pressure (ICP) in conditions like brain injury or intracranial hemorrhage. It draws fluid from the brain parenchyma into the bloodstream.
- Decreases Intraocular Pressure: Mannitol draws water out of the ocular tissues, thus reducing intraocular pressure (IOP) in glaucoma.
- Kidney Filtration: In the kidneys, Mannitol increases the glomerular filtration rate (GFR), which helps prevent or manage acute renal failure by promoting diuresis.
- Electrolyte Shifts: Due to its osmotic properties, Mannitol can alter the distribution of electrolytes (e.g., sodium and potassium), leading to fluid and electrolyte imbalances.

Mannitol 20% Drug Interactions - What to Avoid

Mannitol 20% may interact with several other drugs, leading to alterations in its effects or increased risk of adverse reactions:

- Cardiovascular Medications: Mannitol can enhance the effects of antihypertensive agents, leading to hypotension. Patients on medications like ACE inhibitors, beta-blockers, or calcium channel blockers may experience a significant drop in blood pressure.
- Diuretics: When used in combination with loop diuretics (e.g., furosemide) or thiazide diuretics, Mannitol may cause excessive diuresis and electrolyte imbalances. Close monitoring of electrolytes and renal function is necessary.
- Lithium: Mannitol can increase lithium levels by reducing renal clearance, leading to an increased risk of lithium toxicity. Monitoring lithium levels is advised when these drugs are used together.
- Aminoglycoside Antibiotics: When used concurrently with aminoglycoside antibiotics (e.g., gentamicin), Mannitol may increase the risk of nephrotoxicity.
- Anticoagulants: Mannitol may alter the volume of distribution of anticoagulants such as warfarin, affecting the drug’s effectiveness and increasing bleeding risk.
- Corticosteroids: Concurrent use with corticosteroids may increase the risk of fluid retention and electrolyte imbalances, including hypokalemia.

Patients should always inform their healthcare provider of all the medications they are taking to reduce the risk of dangerous interactions.

Mannitol 20% Adult Dose - Recommended Dosage

The recommended dose of Mannitol 20% varies depending on the clinical indication:

- For Intracranial Pressure Reduction: The initial dose is usually 0.25 to 1 g/kg body weight, administered as a bolus or over a period of 20-60 minutes. The dose may be repeated if necessary.
- For Acute Glaucoma: 1.5-2 g/kg body weight is typically infused over 30-60 minutes.
- For Acute Renal Failure or Oliguria: Mannitol 20% may be administered as 0.25-1 g/kg body weight as an initial dose, followed by continuous infusion if needed.
- For Drug Overdose or Toxin Elimination: The dosing for Mannitol in drug elimination is typically 1-2 g/kg body weight, depending on the specific circumstances.

Mannitol 20% Child Dose - Dosage for Children

In pediatric patients, the dosing for Mannitol 20% typically follows a weight-based approach:

- For Intracranial Pressure or Cerebral Edema: The dose is generally 0.25-1 g/kg body weight, infused over 20-60 minutes.
- For Acute Glaucoma: Pediatric doses are typically around 1-2 g/kg body weight, depending on the child's age and weight.

Careful monitoring of fluid balance, electrolytes, and renal function is required in pediatric patients, as their ability to handle osmotic agents may vary.

Mannitol 20% Renal Dose - Dosage for Kidney Conditions

Mannitol should be avoided or used with caution in patients with renal impairment (e.g., severe renal failure or anuria). In cases of mild-to-moderate renal impairment, dosing adjustments may be required, but close monitoring of renal function, electrolytes, and fluid balance is critical.